159 related articles for article (PubMed ID: 8773403)
1. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-Cabañero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
2. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220
[TBL] [Abstract][Full Text] [Related]
3. Effects of salbutamol and BRL 37344 on diastolic arterial blood pressure, plasma glucose and plasma lactate in rabbits.
Reverte M; Moratinos J
Fundam Clin Pharmacol; 1994; 8(5):417-24. PubMed ID: 7875635
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
5. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes.
Fraeyman N; Van Ermen A; Van de Velde E; Vanscheeuwijck P
Biochem Pharmacol; 1992 Dec; 44(12):2333-8. PubMed ID: 1361733
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of beta 2- and beta 3-adrenoceptors in plasma potassium control in conscious rabbits.
Reverte M; García-Barrado MJ; Hernández-García FJ; Moratinos J
J Auton Pharmacol; 1993 Jun; 13(3):227-36. PubMed ID: 8099912
[TBL] [Abstract][Full Text] [Related]
8. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
Liu YL; Cawthorne MA; Stock MJ
Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
[TBL] [Abstract][Full Text] [Related]
10. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.
Hollenga C; Zaagsma J
Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Leblais V; Pourageaud F; Ivorra MD; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):535-9. PubMed ID: 16012871
[TBL] [Abstract][Full Text] [Related]
15. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
John GW; Doxey JC; Walter DS; Reid JL
Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
[TBL] [Abstract][Full Text] [Related]
16. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway.
Tamaoki J; Tagaya E; Isono K; Nagai A
Biochem Biophys Res Commun; 1998 Jul; 248(3):722-7. PubMed ID: 9703994
[TBL] [Abstract][Full Text] [Related]
17. Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice.
Yoshida T; Hiraoka N; Kondo M
Endocrinol Jpn; 1991 Dec; 38(6):641-6. PubMed ID: 1688048
[TBL] [Abstract][Full Text] [Related]
18. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
19. Effects of two beta3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart.
Kozlovski VI; Chlopicki S; Gryglewski RJ
J Cardiovasc Pharmacol; 2003 May; 41(5):706-13. PubMed ID: 12717100
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
Liu YL; Stock MJ
Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
